Related Experiment Videos
LDL interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement
R Coinu1, G Cherchi, M Formato
1Institute of General Physiology and Biochemistry, University of Sassari, Italy.
Haematologica
|September 1, 1993
Summary
Proteoglycan (PG) populations change in atherosclerosis. Altered PG-LDL interactions, particularly a decreased PGI/PGII ratio, contribute to arterial lipid deposition.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Atherosclerosis Research
Background:
- Proteoglycan (PG)-LDL interactions are implicated in arterial lipid deposition.
- PG populations and structures change in the human aorta during atherosclerotic degeneration.
Purpose of the Study:
- To investigate the interaction of distinct PG populations (PGI and PGII) with LDL.
- To analyze how PG-LDL interactions change with increasing atherosclerotic severity.
Main Methods:
- PGs were extracted and separated into PGI and PGII fractions from human aorta samples.
- PG-LDL interactions were assessed using precipitation assays.
Main Results:
- The ratio of PGI to PGII decreased significantly with advancing atherosclerosis.
- Both PGI and PGII formed insoluble complexes with LDL, with altered inhibition patterns based on PG source.
- PGII from severely affected aortas showed increased cholesterol precipitation with LDL.
Conclusions:
- Structural differences in PGI and PGII influence their interaction with LDL.
- The reduced PGI/PGII ratio in atherosclerosis may promote lipid deposition in the arterial wall.